ReNeuron Ltd, Guildford, Surrey, United Kingdom.
Neurorehabil Neural Repair. 2009 Nov;23(9):895-909. doi: 10.1177/1545968309335978. Epub 2009 Jul 24.
This study investigated behavioral recovery in rats following implanting increasing doses of CTX0E03 cells into the putamen ipsilateral to the stroke damage. Postmortem histological analysis investigated possible mechanisms of behavioral recovery.
. At 4 weeks after middle cerebral artery occlusion (MCAO), rats were treated with 4500, 45,000, or 450,000 CTX0E03 cells or vehicle implanted into the putamen with testing on a battery of tasks preocclusion and postocclusion. Histological examination of brains included assessment of lesion volumes, implant cell survival and differentiation, changes to host brain matrix, angiogenesis, and neurogenesis using immunohistochemical methods.
. Statistically significant dose-related recovery in sensorimotor function deficits (bilateral asymmetry test [BAT; P < .0002] in the mid- and high-dose groups and rotameter test after amphetamine exposure [P < .05] in the high-dose group) was found in the CTX0E03 cell implanted groups compared to the vehicle group. In-life functional improvements correlated with cell dose, though did not correlate with survival of CTX0E03 cells measured at postmortem. Surviving CTX0E03 cells differentiated into oligodendroglial and endothelial phenotypes. MCAO-induced reduction of neurogenesis in the subventricular zone (SVZ) was partially restored to that observed in sham operated controls. No adverse CTX0E03 cell-related effects were observed during in-life observations or on tissue histology.
. This study found that the implantation of CTX0E03 human neural stem cells in rats after MCAO stroke promoted significant behavioral recovery depending on cell dose. The authors propose a paracrine trophic mechanism, which is triggered early after CTX0E03 cell implantation, and which in turn targets restoration of neurogenesis in the SVZ of MCAO rats.
本研究通过向对侧纹状体植入递增剂量的 CTX0E03 细胞,研究大鼠在纹状体损伤后行为恢复情况。对死后组织学分析以探讨行为恢复的可能机制。
在大脑中动脉闭塞(MCAO)后 4 周,大鼠纹状体植入 4500、45000 或 450000 个 CTX0E03 细胞或载体,在闭塞前和闭塞后进行一系列任务测试。用免疫组化方法检测脑损伤体积、植入细胞存活和分化、宿主脑基质变化、血管生成和神经发生。
CTX0E03 细胞植入组与载体组相比,运动感觉功能缺陷(双侧不对称性测试[BAT;中高剂量组 P <.0002]和安非他命暴露后转筒测试[高剂量组 P <.05])有显著的剂量相关性恢复。在体内功能改善与细胞剂量相关,而与死后 CTX0E03 细胞存活无关。存活的 CTX0E03 细胞分化为少突胶质细胞和内皮细胞表型。MCAO 诱导的侧脑室下区(SVZ)神经发生减少部分恢复到假手术对照组的水平。在体内观察或组织学检查中均未观察到 CTX0E03 细胞相关的不良反应。
本研究发现,MCAO 卒中后大鼠植入 CTX0E03 人神经干细胞可促进明显的行为恢复,且取决于细胞剂量。作者提出一种旁分泌营养机制,该机制在 CTX0E03 细胞植入后早期被触发,进而靶向 MCAO 大鼠 SVZ 中的神经发生恢复。